ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Columbia’s Marks Said To Be Cancer Panel New Member; Eight VCP Cregs Awarded

April 2, 1976

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

NSABP Sees Groups To Join Breast Cancer Prevention Trial

September 27, 1991

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013